![Day 2 at the Harvard Breast Cancer Course – Dana-Farber’s Breast Oncology Center](https://oncodaily.com/pub/uploads/2024/07/Screenshot-2024-07-18-183346-1280x675.png)
Day 2 at the Harvard Breast Cancer Course – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X:
“Day 2 at the Harvard Breast Cancer Course was a blast! Watch our video recap to catch key moments from the inspiring sessions and breakthrough discussions!”
Video attached to the post. .
Source: Dana-Farber’s Breast Oncology Center/X
Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a leading institution for cancer treatment and research. It was founded by Sidney Farber on 1947. Currently, the Institute has over 5,000 staff, faculty, and clinicians on board. They manage in excess of 640,000 outpatient visits each year, oversee more than 1,000 hospital discharges annually, and are actively involved in over 1,100 ongoing clinical trials.
As of 2023, Dana-Farber is ranked as the #4 cancer hospital globally. Dana-Farber’s research contributions include the development of Gleevec, a highly successful treatment for chronic myeloid leukemia.